Cite
BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance.
MLA
Robak, Tadeusz, et al. “BCL-2 and BTK Inhibitors for Chronic Lymphocytic Leukemia: Current Treatments and Overcoming Resistance.” Expert Review of Hematology, Oct. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.1080/17474086.2024.2410003.
APA
Robak, T., Witkowska, M., Wolska-Washer, A., & Robak, P. (2024). BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance. Expert Review of Hematology, 1–16. https://doi.org/10.1080/17474086.2024.2410003
Chicago
Robak, Tadeusz, Magdalena Witkowska, Anna Wolska-Washer, and Paweł Robak. 2024. “BCL-2 and BTK Inhibitors for Chronic Lymphocytic Leukemia: Current Treatments and Overcoming Resistance.” Expert Review of Hematology, October, 1–16. doi:10.1080/17474086.2024.2410003.